Cureverse Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 13

Cureverse General Information

Description

Operator of a pharmaceutical research and development company intended for the treatment of brain diseases and multiple sclerosis. The company develops small-molecule drugs for Alzheimer's and Parkinson's disease, ulcerative colitis, and multiple sclerosis, as well as nephritis, and overcomes the cardiac side effects, helping doctors to improve human health and quality of life.

Contact Information

Website
www.cureverse.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Korea Institute of Science and Technology
  • Building V1, 5, Hwarang-ro 14-gil
  • Seoul, Seongbuk
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Korea Institute of Science and Technology
  • Building V1, 5, Hwarang-ro 14-gil
  • Seoul, Seongbuk
  • South Korea

Cureverse Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cureverse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 09-Jul-2025 Completed Pre-Clinical Trials
4. Early Stage VC (Series B) 19-Jan-2025 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 26-Aug-2022 Completed Pre-Clinical Trials
2. Accelerator/Incubator 02-Mar-2022 Completed Startup
1. Seed Round 02-Mar-2022 Completed Startup
To view Cureverse’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cureverse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cureverse Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seoul Biohub Accelerator/Incubator
FuturePlay Venture Capital Minority
Gradient (Korea) Corporation Minority
Industrial Bank of Korea PE/Buyout Minority
KB Securities Investment Bank Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Cureverse FAQs

  • When was Cureverse founded?

    Cureverse was founded in 2021.

  • Where is Cureverse headquartered?

    Cureverse is headquartered in Seoul, South Korea.

  • What is the size of Cureverse?

    Cureverse has 10 total employees.

  • What industry is Cureverse in?

    Cureverse’s primary industry is Drug Discovery.

  • Is Cureverse a private or public company?

    Cureverse is a Private company.

  • What is Cureverse’s current revenue?

    The current revenue for Cureverse is .

  • How much funding has Cureverse raised over time?

    Cureverse has raised $77.3M.

  • Who are Cureverse’s investors?

    Seoul Biohub, FuturePlay, Gradient (Korea), Industrial Bank of Korea, and KB Securities are 5 of 13 investors who have invested in Cureverse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process